| Literature DB >> 34238303 |
Jing Wen1, Tao Pan2, Yun-Chuan Yuan3, Qiu-Shi Huang4, Jian Shen4.
Abstract
BACKGROUND: Postoperative infectious complications (ICs) after surgery for colorectal cancer (CRC) increase in-hospital deaths and decrease long-term survival. However, the methodology for IC preoperative and intraoperative risk assessment has not yet been established. We aimed to construct a risk model for IC after surgery for CRC.Entities:
Keywords: Colorectal cancer; Infectious complications; Risk mode
Mesh:
Year: 2021 PMID: 34238303 PMCID: PMC8268384 DOI: 10.1186/s12957-021-02323-1
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
The baseline characteristics of the patients with and without ICs
| Variables | IC | p† | ||
|---|---|---|---|---|
| With ( | Without ( | |||
| Sex | Male | 58 (9.8%) | 279 (47.0%) | 0.365 |
| Female | 37 (6.2%) | 219 (37.0) | ||
| Age* | Year | 69.2±10.1 | 66.6±11.2 | 0.035‡ |
| BMI* | kg/m2 | 22.9±3.4 | 22.7±3.3 | 0.557‡ |
| Smoking history | Yes | 18 (3.0%) | 97 (16.4%) | 0.905 |
| No | 77 (13.0%) | 401 (67.6%) | ||
| ASA score | < 3 | 79 (13.3%) | 456 (76.9%) | 0.011 |
| ≥3 | 16 (2.7%) | 42 (7.1%) | ||
| Heart disease | Yes | 5 (0.8%) | 34 (5.7%) | 0.573 |
| No | 90 (15.2%) | 464 (78.3%) | ||
| Hypertension | Yes | 27 (4.6%) | 161 (27.2%) | 0.453 |
| No | 68 (11.5%) | 337 (56.8%) | ||
| Chronic pulmonary disease | Yes | 28 (4.7%) | 30 (5.1%) | < 0.001 |
| No | 67 (11.3%) | 468 (78.9%) | ||
| Diabetes mellitus | Yes | 30 (5.1%) | 59 (9.9%) | < 0.001 |
| No | 65 (11.0%) | 439 (74.0%) | ||
| Previous abdominal surgery | Yes | 30 (5.1%) | 143 (24.1%) | 0.574 |
| No | 65(11.0%) | 355 (59.9%) | ||
| Neoadjuvant chemo-radiotherapy | Yes | 12 (2.0%) | 51 (8.6%) | 0.488 |
| No | 83 (14.0%) | 447 (75.4%) | ||
| Preoperative hemoglobin | g/l | 104.5±30.1 | 118.5±24.4 | <0.001‡ |
| Preoperative serum albumin | g/l | 43.5±13.2 | 41.7±16.7 | 0.475‡ |
| Preoperative T stage | < 3 | 11 (1.9%) | 76 (12.8%) | 0.353 |
| ≥3 | 84 (14.1%) | 422 (71.2%) | ||
| Preoperative N stage | Negative | 57 (9.6%) | 295 (49.7%) | 0.890 |
| Positive | 38 (6.4%) | 203 (34.2%) | ||
| Preoperative TNM stage | I | 11 (1.9%) | 69 (11.6%) | 0.788 |
| II | 45 (9.9%) | 221 (37.3%) | ||
| III | 39 (6.6%) | 208 (35.1%) | ||
| Tumor Size* | cm | 4.7±1.4 | 4.5±1.5 | 0.357‡ |
| Tumor Location | Right colon | 20 (3.4%) | 110 (18.5%) | <0.001 |
| Transverse colon | 9 (1.5%) | 7 (1.2%) | ||
| Left colon | 9 (1.5%) | 35 (5.9%) | ||
| Sigmoid | 14 (2.4%) | 87 (14.7%) | ||
| Rectum | 43 (7.3%) | 259 (43.7%) | ||
| Blood transfusion★ | Yes | 29 (5.0%) | 47 (7.9%) | <0.001 |
| No | 66 (11.1%) | 451 (76.1%) | ||
| Surgical approach | Laparoscopic | 33 (5.6%) | 206 (34.7%) | 0.227 |
| Open | 62 (10.5%) | 292 (4.2%) | ||
| Combined organ resection | Yes | 2 (0.3%) | 18 (3.0%) | 0.455 |
| No | 93 (15.7%) | 480 (80.9%) | ||
| Intraoperative blood loss | ml | 168±61.6 | 118.2±55.4 | 0.014‡ |
| Operation time | min | 229.6±68.8 | 204.1±56.6 | <0.001‡ |
| Number of retrieved lymph nodes | - | 15.4±2.9 | 15.1±3.4 | 0.412‡ |
Values in parentheses are percentages unless indicated otherwise
IC infectious complication, BMI body mass index, ASA American Society of Anesthesiologists
*values are mean ± standard deviation
★Preoperative and/or intraoperative blood transfusion
†χ2 test
‡Paired t test
Detailed information of postoperative ICs in the total population
| IC | N (%) |
|---|---|
| Total★ | 95 (16.0%) |
| Wound infection | 6 (1.0%) |
| Anastomosis leakage | 17 (2.9%) |
| Intra-abdominal abscesses and collections | 21 (3.5%) |
| Cholecystitis | 1 (0.2%) |
| Infectious diarrhea | 8 (1.3%) |
| Pneumonia | 53 (8.9%) |
| Clavien-Dindo classification | |
| II | 64 (10.8%) |
| III | 16 (2.7%) |
| IV | 13 (2.2%) |
| V* | 2 (0.3%) |
Values in parentheses are percentages; IC infectious complication
★Six patients had both anastomosis leakage and pneumonia; four patients had both intra-abdominal abscesses and pneumonia; one patient had both infectious diarrhea and pneumonia
*One patient died of sepsis caused by anastomotic leakage and one patient died of respiratory failure caused by severe pneumonia
Fig. 1Risk factors selection using the least absolute shrinkage and selection operator (LASSO) logistic regression model. Final risk factors include chronic pulmonary disease, diabetes mellitus, preoperative and/or intraoperative blood transfusion, and longer operation time. a Optimal parameter (λ) selection in the LASSO model used five-fold cross-validation and minimum criteria. The partial likelihood deviance (binomial deviance) curve was plotted versus log(λ). Dotted vertical lines were drawn at the optimal values by using the minimum criteria and the 1 SE of the minimum criteria (the 1-SE criteria). b LASSO coefficient profiles of the 26 features. A coefficient profile plot was plotted against the log (λ) sequence, and the 4 non-zero coefficients were chosen at the values selected using fivefold cross-validation. SE, standard error
Risk factors for IC following surgery for CRC
| Risk factors | β-coefficient | HR (95% CI) | P |
|---|---|---|---|
| Chronic pulmonary disease (with vs without) | 2.09 | 8.10 (4.22–15.56) | <0.001 |
| Diabetes mellitus (with vs without) | 1.07 | 2.91 (1.61–5.26) | <0.001 |
| Blood transfusion★ (with vs without) | 1.08 | 2.93 (1.78–4.84) | <0.001 |
| Operation time (longer vs shorter) | 1.36 | 3.90 (2.13–7.12) | <0.001 |
IC infectious complication, CRC colorectal cancer, HR hazard ratio, CI confidence interval
★Preoperative and/or intraoperative blood transfusion
Fig. 2Nomogram for predicting IC following surgery for CRC. The nomogram was generated based on chronic pulmonary disease, diabetes mellitus, preoperative and/or intraoperative blood transfusion, and longer operation time
Fig. 3a Calibration curve of the nomogram for predicting IC following surgery for CRC. b Decision curve analysis for predicting IC following surgery for CRC. The x-axis shows the threshold probability. The y-axis represents net benefit. “None” to the assumption that no patient developed IC and “All” refers to the assumption that all patients developed IC. When the score is greater than 0.23, using the nomogram to predict IC adds more net benefit than the treat-none or treat-all strategies